简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2016-06-16 14:43 Patient Safety Movement Announces Three New Patient Safety Challenges
2016-06-15 17:30 Landmark Study Suggests Cranberries Can Decrease Use of Antibiotics
2016-06-15 11:45 Pharmaron Joins the National Cancer Institute’s Chemical Biology Consortium to Fight against Cancer
2016-06-15 10:16 Jardiance® (empagliflozin) significantly reduced the risk of progressive kidney disease in adults with type 2 diabetes with established cardiovascular disease
2016-06-14 14:04 Menarini Group and MSD Extends Global Partnership to the Asia-Pacific Region
2016-06-14 09:24 Herbalife Returns as Title Sponsor of Bali International Triathlon 2016
2016-06-13 17:10 Report on Value of Innovation to HIV/AIDS Treatments in Low- and Middle-Income Countries
2016-06-13 15:07 Ascensia Diabetes Care Renews International Alliance with Medtronic
2016-06-13 14:37 Masimo Announces Full Market Release of Next Generation SpHb® Spot Check Pronto®
2016-06-13 14:32 Market-leading TEVAR Device is First to Surpass 100,000 Devices Distributed Worldwide
2016-06-13 09:10 Samsung Bioepis Announces New Data on Three Anti-TNF-α Biosimilar Molecules at the Annual European Congress on Rheumatology (EULAR 2016)
2016-06-13 09:01 New Jardiance® (empagliflozin) data show that reduced risk for cardiovascular (CV) death was consistent across age groups in adults with type 2 diabetes
2016-06-13 08:57 New study results show Trajenta® (linagliptin) reduces blood sugar in adults with type 2 diabetes at risk for kidney impairment
2016-06-13 08:46 SES Deploys SATMED e-Health Platform in Benin to Improve Treatment of Infectious Tropical Disease
2016-06-08 15:57 Final Subject Enrolled in Early Feasibility Study of the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis
2016-06-08 15:36 TAGRISSO (OSIMERTINIB) SHOWS CLINICAL ACTIVITY IN PATIENTS WITH LEPTOMENINGEAL DISEASE FROM LUNG CANCER
2016-06-08 13:41 Win a Fishing Trip with President Jimmy Carter by Committing to Zero Preventable Deaths by 2020
2016-06-08 12:22 Data Presented at ASCO 2016 Builds upon Foundation of Abraxane® Plus Gemcitabine as a First-Line Treatment in Patients with Metastatic Pancreatic Cancer
2016-06-08 11:56 Pooled Data from Meta-Analysis Suggest Significant Overall Survival Benefit of Investigational REVLIMID® Maintenance Following Autologous Stem Cell Transplant in Multiple Myeloma
2016-06-08 10:13 DURVALUMAB MONOTHERAPY DEMONSTRATES EFFICACY IN UROTHELIAL BLADDER CANCER

Business Wire Weibo

Press Releases

Latest Releases